Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05898594 · ClinicalTrials.gov registry record · NA

Lung Cancer Screening in High-risk Black Individuals

A NA study of Lung Cancer and Lung Carcinoma, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
2
Study locations

NCT05898594 is a NA study of Lung Cancer and Lung Carcinoma that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 900 participants, roughly in line with the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05898594, a NA study of Lung Cancer and Lung Carcinoma, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan

Conditions Studied

Lung Cancer Lung Carcinoma

Interventions

  • PROCEDURE Low-dose Computed Tomography

Study Locations (2)

Illinois

  • University of Chicago - Chicago

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2023-09-06
Est. Completion 2028-06-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05898594

The ClinicalTrials.gov registry entry for NCT05898594 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Low-dose Computed Tomography is the first listed.

NCT05898594 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05898594 about?

NCT05898594 is a clinical study titled "Lung Cancer Screening in High-risk Black Individuals". The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose comp...

What is the current status of trial NCT05898594?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-09-06. Estimated completion is 2028-06-30.

What conditions does trial NCT05898594 study?

This clinical trial studies the following conditions: Lung Cancer, Lung Carcinoma.

What interventions are being tested in trial NCT05898594?

The interventions under investigation include: Low-dose Computed Tomography (PROCEDURE).

Who is sponsoring clinical trial NCT05898594?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05898594 being conducted?

This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Lung Carcinoma

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.